Related Experiment Video
Updated: Feb 20, 2026

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods
Published on: December 21, 2019
Small-molecule PS10 inhibits PRRSV replication by targeting HSP90 and multiple viral non-structural proteins
Yongjie Chen1, Jingxing Wang1, Haotong Lu1
1Guangdong Laboratory for Lingnan Modern Agriculture, State Key Laboratory of Animal Disease Control and Prevention, Key Laboratory of Zoonosis Prevention and Control of Guangdong Province, College of Veterinary Medicine, South China Agricultural University, , Guangzhou, Guangdong, People's Republic of China.
A new compound, PS10, effectively inhibits porcine reproductive and respiratory syndrome virus (PRRSV) replication by targeting viral proteins and host factors like HSP90. This discovery offers a promising avenue for developing broad-spectrum antiviral therapies against PRRSV.
Area of Science:
- Virology
- Drug Discovery
- Immunology
Background:
- Porcine reproductive and respiratory syndrome virus (PRRSV) poses a significant threat to global swine production and food security.
- Existing vaccines for PRRSV often exhibit limited cross-protection against diverse viral strains, necessitating the development of alternative treatments.
- The genetic variability of PRRSV complicates effective disease management strategies.
Purpose of the Study:
- To identify novel antiviral compounds targeting PRRSV replication.
- To elucidate the mechanism of action of identified inhibitors.
- To evaluate the potential of new therapeutic agents for controlling PRRSV infections.
Main Methods:
- Compound library screening to identify PRRSV inhibitors.
- Antiviral assays in cell cultures (Marc-145 cells) and primary porcine alveolar macrophages.
- Mechanistic studies including heat shock protein 90 (HSP90) expression analysis, cytokine profiling, viral non-structural protein quantification, molecular docking, and cellular thermal shift assays (CETSA).
Main Results:
- 2-[(2,4-dihydroxyphenyl) sulfonyl] isoindoline-4,6-diol (PS10) was identified as a potent inhibitor of PRRSV replication.
- PS10 demonstrated dose-dependent antiviral activity across different PRRSV strains and host cells, with low cytotoxicity.
- PS10 suppressed PRRSV-induced HSP90 expression, reduced pro-inflammatory cytokine production, and decreased levels of viral non-structural proteins (nsp2, nsp3, nsp10, nsp11) through direct binding.
Conclusions:
- PS10 is a promising antiviral agent effective against PRRSV by targeting critical viral and host factors.
- The study provides insights into PS10's mechanism, including its interaction with viral proteins and modulation of host responses.
- PS10 offers a potential foundation for developing novel, broad-spectrum antiviral therapies for PRRSV and potentially other viral infections.
Related Concept Videos
Subviral Agents
Viruses with RNA Genomes

